Replication stress marker points to ovarian cancers that may yield to ALC1 targeting
New research shows that removing the chromatin remodeler ALC1 sensitizes a broad range of ovarian cancer models to PARP inhibitors ...
Tag: ALC1
POPULAR NEWS
-
Systematic review maps end-of-life psychosocial and spiritual needs in physical disability
-
Text Message Campaign Reached Only a Third of Patients Overdue for Colorectal Cancer Screening
-
FOXO1 Emerges as Candidate Regulator and Biomarker in Hip Dysplasia
-
Regulators, developers and clinicians in Shenzhen voice concerns over medical AI governance